InDex Pharmaceuticals Holding AB (publ) interim report January - June 2019
(WorldNews Sweden)

Last patient enrolled in the CONDUCT study Period April - June 2019 Revenues amounted to SEK 0.0 (0.0) million Operating result amounted to SEK -17.7 (-26.0) million Result after tax amounted to SEK -17.7 (-26.0) million, corresponding to SEK -0.26 per share (-0.42) before and after dilution Cash flow from operating activities amounted to SEK -13.9 (-19.7) million Period January - June 2019 Revenues amounted to SEK 0.0 (0.1) million Operating result amounted to SEK -34.9 (-44.7) million Result after tax amounted to SEK -34.9 (-44.7) million, corresponding to SEK -0.51 per share (-0.72) before and after dilution Cash flow from operating activities amounted to SEK -32.5 (-42.6) million Cash...